| Ashley Marie Lloyd, MD | |
|
1 Childrens Pl, Saint Louis, MO 63110-1081 | |
| (314) 454-6000 | |
| Not Available |
| Full Name | Ashley Marie Lloyd |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Location | 1 Childrens Pl, Saint Louis, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316444110 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2023013142 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Marie Lloyd, MD 660 S Euclid Ave, Saint Louis, MO 63110-1010 Ph: () - | Ashley Marie Lloyd, MD 1 Childrens Pl, Saint Louis, MO 63110-1081 Ph: (314) 454-6000 |
News Archive
The preclinical contract research organization Absorption Systems, a global leader in pharmacokinetic testing of drugs, announces that it has entered into a partnership with the Indian pharmaceutical consulting firm Synerzys Lifecare Pvt Ltd.
MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced preliminary results from its ongoing Phase I study of small activating RNA candidate MTL-CEBPA in advanced liver cancer.
Texas Tribune: "For years, the state paid private providers who care for people with disabilities to help the clients decide how many services they need and how intensive they should be. But an 11th-hour change state lawmakers inserted into the budget last session stripped the private providers of this case management responsibility, giving it instead to local, quasi-governmental Mental Retardation Authorities, who administer publicly funded services to people with disabilities.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
› Verified 8 days ago
Mark F Stroble, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 12399 Gravois Rd, Ste 120, Saint Louis, MO 63127 Phone: 314-843-3828 Fax: 314-843-3052 | |
Arya W Namin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 607 S New Ballas Rd Ste 2300, Saint Louis, MO 63141 Phone: 314-251-6394 Fax: 314-251-4235 | |
Dr. Ethan Craig, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Dr. Richard A Chole, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Pl Ste 3s, Ste 3s, Saint Louis, MO 63110 Phone: 314-454-6162 Fax: 314-454-2174 | |
Dr. Timothy J Reichert, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 621 S New Ballas Rd, Suite 622a, Saint Louis, MO 63141 Phone: 314-872-8340 Fax: 314-872-8399 | |
Dr. Cameron Connelly Wick, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Matthew Lee Rohlfing, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 |